Hirotaka Iwase
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 51
- Cancer Genomics and Diagnostics 19
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 55
- Cancer Treatment and Pharmacology 26
- Genetics top 1%
- Estrogen and related hormone effects 57
- BRCA gene mutations in cancer 14
- Molecular Biology top 2%
-
- Breast Lesions and Carcinomas 15
-
- Advanced Breast Cancer Therapies 20
- Co-authors
- Yutaka YamamotoHiroko YamashitaTatsuya ToyamaShunzo KobayashiZhenhuan ZhangYoko OmotoHiroshi SugiuraYukio Ando
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Breast Cancer (33 papers)Breast Cancer Research and Treatment (12 papers)Cancer Science (11 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hirotaka Iwase
207 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 2.2k
- Oncology 3.0k
- Genetics 1.5k
- Molecular Biology 2.9k
- Pathology and Forensic Medicine 607
Countries citing papers authored by Hirotaka Iwase
This map shows the geographic impact of Hirotaka Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotaka Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotaka Iwase more than expected).
Fields of papers citing papers by Hirotaka Iwase
This network shows the impact of papers produced by Hirotaka Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotaka Iwase. The network helps show where Hirotaka Iwase may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirotaka Iwase, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2018 | 50 | |
| 3 | 2017 | 31 | |
| 4 | 2015 | 52 | |
| 5 | 2010 | 53 | |
| 6 | 2010 | 62 | |
| 7 | Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse. | 2009 | 10 |
| 8 | 2009 | 55 | |
| 9 | 2009 | 45 | |
| 10 | 2008 | 0 | |
| 11 | 2008 | 7 | |
| 12 | 2006 | 54 | |
| 13 | 2006 | 2 | |
| 14 | 2005 | 90 | |
| 15 | 2003 | 125 | |
| 16 | 2003 | 15 | |
| 17 | Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer. | 1997 | 11 |
| 18 | 1997 | 46 | |
| 19 | [Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer]. | 1996 | 2 |
| 20 | 1990 | 1 |
About Hirotaka Iwase
Hirotaka Iwase is a scholar working on Cancer Research, Oncology and Genetics, having authored 210 papers that have together received 6.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (57 papers), HER2/EGFR in Cancer Research (55 papers), Breast Cancer Treatment Studies (51 papers), Cancer Treatment and Pharmacology (26 papers), Advanced Breast Cancer Therapies (20 papers), Cancer Genomics and Diagnostics (19 papers), Breast Lesions and Carcinomas (15 papers) and BRCA gene mutations in cancer (14 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.0k citations) and Genetics (1.5k citations). Hirotaka Iwase has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Yutaka Yamamoto, Hiroko Yamashita, Tatsuya Toyama, Shunzo Kobayashi, Zhenhuan Zhang, Yoko Omoto, Hiroshi Sugiura, Yukio Ando, Mutsuko Yamamoto‐Ibusuki and Yoshitaka Fujii. Their work appears in journals such as Breast Cancer, Breast Cancer Research and Treatment, Cancer Science, Journal of Clinical Oncology and International Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.